N. E. Gefen

834 total citations
8 papers, 681 citations indexed

About

N. E. Gefen is a scholar working on Molecular Biology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, N. E. Gefen has authored 8 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 1 paper in Public Health, Environmental and Occupational Health. Recurrent topics in N. E. Gefen's work include MicroRNA in disease regulation (4 papers), RNA Interference and Gene Delivery (2 papers) and Cancer-related molecular mechanisms research (2 papers). N. E. Gefen is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA Interference and Gene Delivery (2 papers) and Cancer-related molecular mechanisms research (2 papers). N. E. Gefen collaborates with scholars based in Israel, United States and Germany. N. E. Gefen's co-authors include Shai Izraeli, Vera Binder, Arndt Borkhardt, Mahesh Mansukhani, Shlomit Gilad, Yael Spector, Avital Dov, Karin Ashkenazi, Daisuke Nonaka and Junjie Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Leukemia.

In The Last Decade

N. E. Gefen

7 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. E. Gefen Israel	6	550	528	67	56	45	8	681
Alba Mota Spain	9	226 0.4×	104 0.2×	65 1.0×	52 0.9×	70 1.6×	13	364
Tania Witte Germany	10	316 0.6×	143 0.3×	34 0.5×	37 0.7×	27 0.6×	14	396
M Zipeto United States	9	575 1.0×	167 0.3×	38 0.6×	61 1.1×	82 1.8×	13	674
Sue Ghosh United States	5	269 0.5×	143 0.3×	57 0.9×	144 2.6×	74 1.6×	5	474
Qiu‐Hong Tian China	9	327 0.6×	138 0.3×	76 1.1×	58 1.0×	48 1.1×	18	419
Fanfei Kong China	15	422 0.8×	378 0.7×	43 0.6×	151 2.7×	49 1.1×	26	626
Abhaya Paladugu United States	7	217 0.4×	174 0.3×	101 1.5×	133 2.4×	16 0.4×	9	430
Martina Fröhlich Germany	7	162 0.3×	103 0.2×	54 0.8×	73 1.3×	18 0.4×	17	315
Yiren Xiao United States	7	276 0.5×	128 0.2×	49 0.7×	130 2.3×	81 1.8×	11	415
Audrey Vallée France	14	213 0.4×	260 0.5×	226 3.4×	235 4.2×	37 0.8×	28	490

Countries citing papers authored by N. E. Gefen

Since Specialization

Citations

This map shows the geographic impact of N. E. Gefen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. E. Gefen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. E. Gefen more than expected).

Fields of papers citing papers by N. E. Gefen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. E. Gefen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. E. Gefen. The network helps show where N. E. Gefen may publish in the future.

Co-authorship network of co-authors of N. E. Gefen

This figure shows the co-authorship network connecting the top 25 collaborators of N. E. Gefen. A scholar is included among the top collaborators of N. E. Gefen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. E. Gefen. N. E. Gefen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Binder, Vera, et al.. (2012). MiR-125 in normal and malignant hematopoiesis. Leukemia. 26(9). 2011–2018. 151 indexed citations

2.

Greenberg, Eyal, Liat Hershkovitz, Orit Itzhaki, et al.. (2011). Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs. PLoS ONE. 6(4). e18936–e18936. 74 indexed citations

3.

Gefen, N. E., et al.. (2010). Acquired resistance to 6-thioguanine in melanoma cells involves the repair enzyme O⁶- methylguanine-DNA methyltransferase (MGMT).. Cancer Biology & Therapy. 9(1). 49–55. 9 indexed citations

4.

Lebanony, Danit, Hila Benjamin, Shlomit Gilad, et al.. (2009). Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma. Journal of Clinical Oncology. 27(12). 2030–2037. 326 indexed citations

5.

Gefen, N. E., Vera Binder, Markéta Žaliová, et al.. (2009). Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia. 24(1). 89–96. 92 indexed citations

6.

Tanić, Nikola, Bogomir Dimitrijević, Nasta Tanić, et al.. (2006). Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines.. PubMed. 26(3A). 2137–42. 26 indexed citations

7.

Gefen, N. E., et al.. (1968). EXPERIMENT OF MASS AEROGENIC VACCINATION OF HUMANS AGAINST ANTHRAX. Defense Technical Information Center (DTIC). 1 indexed citations

8.

Gefen, N. E., et al.. (1958). [Reactivity to and effectiveness of aerogenic vaccination against certain zoonoses].. PubMed. 86(12). 34–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact